Comparison: Compounded Semaglutide vs Wegovy
Both items are reviewed at GLP1 One Rx against the v3.0 transparency rubric and published clinical evidence.
Key differentiators
- Active ingredient: same (semaglutide), different supply chain.
- FDA status: Wegovy is FDA-approved; compounded is not.
- Pharmacy: Wegovy from Novo Nordisk under FDA-inspected facilities; compounded from 503A pharmacies (USP <797>) or 503B facilities (cGMP).
- Price: Wegovy ~$1,349/mo list price; $349/mo NovoCare self-pay pen; compounded from $59/mo plus a yearly membership (Collective) or $119/mo on NexLife’s 12-month plan.
- Quality flag: only semaglutide base — no salt forms (sodium/acetate).